home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

NIGMS-Funded RNA Research Named Breakthrough of the Year

  January, 23 2003 2:13
your information resource in human molecular genetics
Science magazine has declared advances in understanding molecules called "small RNAs" as the top scientific achievement of 2002. This "Breakthrough of the Year" research was funded by the National Institute of General Medical Sciences, a component of the National Institutes of Health, U.S. Department of Health and Human Services.

Once thought to be mere foot soldiers that carry out DNA's orders, RNA molecules are now known to play a significant role in controlling gene expression and other cellular activities. NIGMS grantees whose discoveries are included in the Science Breakthrough of the Year include Dr. Andrew Fire of the Carnegie Institution of Washington in Baltimore, Md.; Dr. Craig Mello of the University of Massachusetts Medical School in Worcester, Dr. Gregory Hannon and Dr. Shiv Grewal of Cold Spring Harbor Laboratory in New York, Dr. Martin Gorovsky of the University of Rochester in New York, and Dr. C. David Allis of the University of Virginia Health System in Charlottesville.

Two other NIGMS-funded research areas were named among the Science magazine top 10 achievements for 2002: research on TRP (transient receptor potential) ion channels that allow us to taste spicy hot and minty cool sensations, and advances in a technology called cryoelectron tomography, which makes it possible to view cellular structures in three dimensions.

NIGMS supports basic biomedical research and training nationwide. NIGMS-funded studies lay the foundation for advances in disease diagnosis, treatment, and prevention.

Linda Joy
(301) 496-7301

Message posted by: Rashmi Nemade

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.